Riehl melanosis
https://en.wikipedia.org/wiki/Riehl_melanosis
☆ Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo. relevance score : -100.0%
References
Riehl Melanosis 32491369 NIH
Riehl melanosis ni a mọ nigbagbogbo bi dermatitis olubasọrọ pigmented. O jẹ iru ipo awọ ara ti o fa nipasẹ awọn nkan ti ara korira, nigbagbogbo nfa nipasẹ lofinda ati awọn nkan miiran ti a rii ni awọn ọja ohun ikunra. Pelu tito lẹtọ bi iru dermatitis, Riehl melanosis ṣe afihan awọn ayipada pigmentation ni awọ ara, pẹlu awọn ami kekere ti irritation nikan. O wọpọ julọ ni awọn eniyan ti o ni awọn ohun orin awọ dudu. Iwadi aipẹ ti ṣawari imunadoko ti mid-fluence QSNY 1064-nm itọju laser fun sisọ awọn pigmentation jinle ti o ni nkan ṣe pẹlu Riehl melanosis. Iwadi miiran ni idapo awọn oriṣiriṣi awọn itọju ailera, pẹlu low-fluence 1064-nm Q-switched Nd: YAG lesa, ipara hydroquinone, ati tranexamic acid oral, ti o fa ilọsiwaju pataki fun ọpọlọpọ awọn alaisan.
Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
Research Advances in the Treatment of Riehl’s Melanosis 37168093 NIH
Riehl's melanosis jẹ iru ipo awọ ti o fa nipasẹ olubasọrọ pẹlu awọn nkan ti ara korira ati ifihan si imọlẹ oorun. O yorisi iyara, eleyi ti grẹy ti ra awọ alawọ ti awọ ara, eyiti o le kan awọn alaisan mejeeji ni ọpọlọ ati ti ara. Lakoko ti idi gangan ti Riehl's melanosis ko jẹ aimọ, iwadi ti o wa tẹlẹ tọkasi ọna asopọ to lagbara pẹlu ifihan ti ara korira. Fun itọju naa, oogun ibile mejeeji ati itọju ailera laser ni a ti gbiyanju, nigbagbogbo lẹgbẹẹ lilo awọn aṣoju bleaching ti a lo si awọ ara. Itọju ailera lesa, ni pataki ni lilo Q-switched Nd:YAG lesa, ti ṣe afihan awọn abajade ileri fun itọju Riehl's melanosis. Apapọ awọn ọna itọju oriṣiriṣi ti yori si awọn abajade rere.
Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.